Cargando…

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies

miR-203 is a tumour suppressor microRNA (miRNA). We studied the methylation of hsa-miR-203 in 150 samples including acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML), chronic lymphocytic leukaemia (CLL) and non-Hodgkin’s lymphoma (NHL) by methylation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chim, Chor Sang, Wong, Kwan Yeung, Leung, Chung Ying, Chung, Lap Ping, Hui, Pak Kwan, Chan, Sau Yan, Yu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373446/ https://www.ncbi.nlm.nih.gov/pubmed/21323860 http://dx.doi.org/10.1111/j.1582-4934.2011.01274.x

Ejemplares similares

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
por: Wong, Kwan Yeung, et al.
Publicado: (2011)

Epigenetic inactivation of the MIR129-2 in hematological malignancies
por: Wong, Kwan-Yeung, et al.
Publicado: (2013)

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011)

Epigenetic silencing of LPP/miR-28 in multiple myeloma
por: Li, Zhenhai, et al.
Publicado: (2018)

Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFκB pathway
por: Wang, Lu Qian, et al.
Publicado: (2013)

Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways
por: Wang, Lu Qian, et al.
Publicado: (2015)

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact
por: Li, Zhenhai, et al.
Publicado: (2019)

Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas
por: Yim, Rita Lh, et al.
Publicado: (2014)

hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
por: HE, JIN-HUA, et al.
Publicado: (2013)

Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia
por: Wang, Lu Qian, et al.
Publicado: (2016)

Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2015)

Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023)

Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
por: Wang, Lu Qian, et al.
Publicado: (2014)

DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas
por: Yim, Rita Lok-Hay, et al.
Publicado: (2012)

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2021)

High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes
por: Bai, Yinlei, et al.
Publicado: (2016)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
por: Wong, Kwan Yeung, et al.
Publicado: (2013)

Atypical burkitt's lymphoma transforming from follicular lymphoma
por: Hwang, Yu Y, et al.
Publicado: (2011)

Antileukemic Activity of hsa-miR-203a-5p by Limiting Glutathione Metabolism in Imatinib-Resistant K562 Cells
por: Singh, Priyanka, et al.
Publicado: (2022)

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2018)

Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy
por: Zhang, Min Yue, et al.
Publicado: (2020)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa‐miR‐1184 and releasing AJUBA and inactivating Hippo/YAP signalling
por: Wang, Xu, et al.
Publicado: (2020)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

Survival of >20 years in a myeloma patient with an unusual combination of t(14;16) and hyperdiploidy: A case report
por: CHIM, CHOR SANG, et al.
Publicado: (2013)

miR-203 drives breast cancer cell differentiation
por: Martínez-Illescas, Nuria G., et al.
Publicado: (2023)

The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies
por: Huntly, Brian
Publicado: (2013)

miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC)
por: Chen, Jiajia, et al.
Publicado: (2020)

Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis
por: Zhang, Chunyu, et al.
Publicado: (2021)

“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
por: Bertero, Thomas, et al.
Publicado: (2012)

MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
por: Petty, Robert D., et al.
Publicado: (2016)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
por: Navarro, A, et al.
Publicado: (2016)

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
por: Tao, Wenhua, et al.
Publicado: (2016)

Exosome-mediated miR-25/miR-203 as a potential biomarker for esophageal squamous cell carcinoma: improving early diagnosis and revealing malignancy
por: Liu, Zhun, et al.
Publicado: (2021)

Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma
por: Wang, Fenglin, et al.
Publicado: (2018)

MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells()
por: Aakko, Sofia, et al.
Publicado: (2018)

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pkrt0qlp33g1ostrc796s7055h